|
Index of reports
> Cases resulting in life threatening events (2)
Below is the selection of adverse event reports related to Glucovance (Glyburide / Metformin) that includes cases resulting in life threatening events.
Adverse event in 55 year old female receiving Glucovance (Glyburide / Metformin)
Reported by a consumer/non-health professional from United States on 2007-06-27
Patient: 55 year old female, weighing 148.0 kg (325.6 pounds)
Adverse reactions / side effects: Weight Increased, Blood Glucose Decreased, Dyspnoea, Oedema Peripheral, Hypoglycaemia, Pulmonary Oedema, Hypoxia, Cardiac Failure Congestive
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Avandia
Dosage: 4mg twice per day
Administration route: Oral
Glucovance
Other drugs received by patient: Lisinopril; Aspirin; Celexa; Gabapentin
Adverse event in 55 year old female receiving Glucovance (Glyburide / Metformin)
Reported by a consumer/non-health professional from United States on 2007-06-21
Patient: 55 year old female, weighing 148.0 kg (325.6 pounds)
Adverse reactions / side effects: Weight Increased, Blood Glucose Decreased, Dyspnoea, Oedema Peripheral, Hypoglycaemia, Pulmonary Oedema, Hypoxia, Cardiac Failure Congestive
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Avandia
Dosage: 4mg twice per day
Administration route: Oral
Indication: Diabetes Mellitus non-Insulin-Dependent
Glucovance
Other drugs received by patient: Lisinopril; Aspirin; Celexa; Gabapentin
|
